Summary: In a sham-controlled, blinded trial in obese polycystic ovary syndrome, electroacupuncture modestly reduced BMI and improved metabolic markers, lipids, and quality of life over 12 weeks, with benefits sustained to 24 weeks and no serious adverse events.
PICO Summary
| Element | Detail |
|---|---|
| Population | 106 women aged 18–45 with obese polycystic ovary syndrome; patient- and assessor-blinded, sham-controlled randomised trial, China. |
| Intervention | Electroacupuncture over 12 weeks (24 sessions, tapering from 3 to 1 per week), with 12 weeks of follow-up. |
| Comparison | Sham electroacupuncture on the same schedule. |
| Outcome | At 12 weeks, BMI was lower with electroacupuncture (between-group difference -1.50; 95% CI -1.83 to -1.17; p<.001), sustained at 24 weeks (-1.58; p<.001). Waist-hip ratio, body fat mass, fasting glucose, insulin and HOMA-IR, lipids, and PCOSQ quality-of-life scores all improved. No serious adverse events. |
Electroacupuncture in obese PCOS
RCT · obese PCOS · 12 weeks
Sham-controlled, blinded electroacupuncture lowered BMI by about 1.5 units and improved metabolic and quality-of-life measures, with benefits sustained to 24 weeks and no serious adverse events.
Expert Commentary
This trial deserves more attention than the typical acupuncture study because of its design: patient- and assessor-blinding with a sham comparator addresses the placebo and expectation effects that plague much of the literature, so the modest but consistent benefits carry more weight than an open-label result would. The improvements spanned anthropometric, glycaemic, lipid, and quality-of-life domains and persisted three months after treatment ended, which is reassuring for durability, and the safety profile was clean. I would keep the effect size in proportion: a BMI difference of about 1.5 units is real but modest, and the question of clinical meaningfulness for reproductive and metabolic outcomes in PCOS remains. The honest limitations include a single-centre Chinese setting that may limit generalisability, a relatively short total horizon of 24 weeks, the inherent difficulty of fully convincing sham acupuncture, and no reproductive hard endpoints such as ovulation or pregnancy rates. Can I use this with my patients? Cautiously, as an adjunct. For a motivated patient with obese PCOS seeking non-pharmacological options, electroacupuncture is a reasonable complement to first-line lifestyle modification, framed as offering modest metabolic and quality-of-life gains rather than replacing established management, and access to skilled providers will often be the practical limiting factor.
References
Wang Y, Fu L, Wang J, et al. Effect of electroacupuncture on metabolic level and quality of life in patients with obese polycystic ovary syndrome: a randomized controlled trial. Front Endocrinol (Lausanne). 2026;16:1723419. doi:10.3389/fendo.2025.1723419